Fundraising FoxOruka Therapeutics Inc
NASDAQ: ORKA2 known investors
Find your way into Oruka Therapeutics Inc
Sign up to see every warm intro you have to Oruka Therapeutics Inc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oruka Therapeutics Inc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Oruka is a biopharmaceutical company developing monoclonal antibody therapies aimed at treating plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory conditions with fewer annual doses. Its pipeline includes clinical-stage candidates ORKA-001 and ORKA-002 for moderate-to-severe plaque psoriasis.
Founders & leadership
LK
Lawrence KleinChief Executive Officer and Director
Investors · 2
Frequently asked questions
- What does Oruka Therapeutics Inc do?
- Oruka is a biopharmaceutical company developing monoclonal antibody therapies aimed at treating plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory conditions with fewer annual doses. Its pipeline includes clinical-stage candidates ORKA-001 and ORKA-002 for moderate-to-severe plaque psoriasis.
- Who are Oruka Therapeutics Inc's investors?
- Oruka Therapeutics Inc's investors include SR One Capital Management, Viking Global.